The Latest

Join scientists from around the world, September 21-23, in Málaga, Spain, for Science Summit 2026: Networked for Life: Nuclear Receptors in Age-related Diseases, to discover the latest advancements in nuclear receptor research, spanning fundamental mechanisms to clinical applications in age-related diseases. Researchers and trainees are invited to submit abstracts through Thursday, July 9. Outstanding abstracts will be selected for oral presentation during the Bright Sparks Sessions, providing an opportunity to showcase innovative research and engage with leaders in the field.

Explore the latest program details for Clinical Endocrinology Update (CEU) 2026. Mark your calendars for October 22-24 for three days of top-notch endocrine education. Attend online to learn about recent advances in treating endocrine-related conditions. Review complex cases and strengthen skills in diagnosis and disease management. Register now to secure the best rates.

Are you ready for ABIM’s Endocrinology, Diabetes, and Metabolism Certification Exam? With over a decade of experience, we are confident that our program will help you succeed on this test and enhance your clinical critical thinking skills. Your registration includes a printed copy of the Endocrine Board Review (2026) 18th Edition Book, interactive practice exams, and live study sessions with experts.

This Thematic Issue comprises articles coauthored by speakers scheduled to present at ENDO 2026. These articles cover a wide range of cutting-edge topics in endocrinology and were all published by Endocrine Society Journals within the last year.

Prepare with confidence using the Endocrine Board Review, 18th Edition, the trusted resource for fellows and endocrinologists. With more than 220 case-based questions aligned to the ABIM exam blueprint, it keeps your study focused and efficient. Pre-order now to get ahead, with early access to the interactive practice exam in July and receive your hard copy in August.

Host Aaron Lohr talks with Dennis M. Black, PhD, from the University of California, San Francisco, Richard Eastell, MBChB, PhD, FRCP, FMedSci, from the University of Sheffield, and Mary L. Bouxsein, PhD, from Harvard Medical School about the SABRE Project and its significant impact on osteoporosis clinical trials. This episode was inspired by the work of the Endocrine Society Bone and Mineral Special Interest Group.

Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, talks with regular contributor Amal Shibli Rahhal, MD, from the University of Iowa, and guest expert Thomas Weber, MD, from Duke Health. Together, they discuss “Anti-fracture efficacy of 5 or 10 yearly zoledronate in women aged 50 to 60 years,” published in the April 2026 issue of JCEM, and consider how these findings may inform decisions around early treatment strategies, risk assessment, and long-term fracture prevention in clinical practice.